Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine

J Neurochem. 2008 May;105(3):677-89. doi: 10.1111/j.1471-4159.2007.05174.x. Epub 2008 Jan 10.

Abstract

Excitotoxicity and disrupted energy metabolism are major events leading to nerve cell death in neurodegenerative disorders. These cooperative pathways share one common aspect: triggering of oxidative stress by free radical formation. In this work, we evaluated the effects of the antioxidant and energy precursor, levocarnitine (L-CAR), on the oxidative damage and the behavioral, morphological, and neurochemical alterations produced in nerve tissue by the excitotoxin and free radical precursor, quinolinic acid (2,3-pyrindin dicarboxylic acid; QUIN), and the mitochondrial toxin, 3-nitropropionic acid (3-NP). Oxidative damage was assessed by the estimation of reactive oxygen species formation, lipid peroxidation, and mitochondrial dysfunction in synaptosomal fractions. Behavioral, morphological, and neurochemical alterations were evaluated as markers of neurotoxicity in animals systemically administered with L-CAR, chronically injected with 3-NP and/or intrastriatally infused with QUIN. At micromolar concentrations, L-CAR reduced the three markers of oxidative stress stimulated by both toxins alone or in combination. L-CAR also prevented the rotation behavior evoked by QUIN and the hypokinetic pattern induced by 3-NP in rats. Morphological alterations produced by both toxins (increased striatal glial fibrillary acidic protein-immunoreactivity for QUIN and enhanced neuronal damage in different brain regions for 3-NP) were reduced by L-CAR. In addition, L-CAR prevented the synergistic action of 3-NP and QUIN to increase motor asymmetry and depleted striatal GABA levels. Our results suggest that the protective properties of L-CAR in the neurotoxic models tested are mostly mediated by its characteristics as an antioxidant agent.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Brain / drug effects
  • Brain / metabolism*
  • Carnitine / pharmacology*
  • Convulsants / toxicity
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Energy Metabolism / drug effects*
  • Energy Metabolism / physiology
  • Free Radicals / metabolism
  • Gliosis / drug therapy
  • Gliosis / physiopathology
  • Gliosis / prevention & control
  • Lipid Peroxidation / drug effects
  • Lipid Peroxidation / physiology
  • Male
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Movement Disorders / drug therapy
  • Movement Disorders / physiopathology
  • Movement Disorders / prevention & control
  • Nerve Degeneration / drug therapy
  • Nerve Degeneration / physiopathology
  • Nerve Degeneration / prevention & control
  • Neurodegenerative Diseases / drug therapy*
  • Neurodegenerative Diseases / metabolism
  • Neurodegenerative Diseases / physiopathology
  • Neuroprotective Agents / pharmacology
  • Neurotoxins / antagonists & inhibitors*
  • Neurotoxins / metabolism
  • Nitro Compounds / toxicity
  • Oxidative Stress / drug effects*
  • Oxidative Stress / physiology
  • Propionates / toxicity
  • Quinolinic Acid / metabolism
  • Quinolinic Acid / toxicity
  • Rats
  • Rats, Wistar
  • Reactive Oxygen Species / metabolism
  • Treatment Outcome

Substances

  • Antioxidants
  • Convulsants
  • Free Radicals
  • Neuroprotective Agents
  • Neurotoxins
  • Nitro Compounds
  • Propionates
  • Reactive Oxygen Species
  • Quinolinic Acid
  • 3-nitropropionic acid
  • Carnitine